Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Sells 1,525 Shares of Henry Schein, Inc. (HSIC)

Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 11.5% during the second quarter, Holdings Channel reports. The institutional investor owned 11,706 shares of the company’s stock after selling 1,525 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Henry Schein were worth $2,142,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. SpiderRock Advisors LLC acquired a new stake in shares of Henry Schein during the first quarter worth about $102,000. Lee Financial Co acquired a new stake in shares of Henry Schein during the second quarter worth about $161,000. JNBA Financial Advisors acquired a new stake in shares of Henry Schein during the first quarter worth about $170,000. Westside Investment Management Inc. acquired a new stake in shares of Henry Schein during the first quarter worth about $168,000. Finally, Peddock Capital Advisors LLC increased its stake in shares of Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares during the period. Hedge funds and other institutional investors own 90.60% of the company’s stock.

Shares of Henry Schein, Inc. (NASDAQ:HSIC) opened at 167.94 on Wednesday. The stock has a market cap of $13.28 billion, a P/E ratio of 24.54 and a beta of 1.09. Henry Schein, Inc. has a 52-week low of $146.23 and a 52-week high of $186.99. The firm’s 50-day moving average price is $180.63 and its 200-day moving average price is $175.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, topping the consensus estimate of $1.73 by $0.02. The business had revenue of $3.06 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.64 EPS. Equities analysts predict that Henry Schein, Inc. will post $7.27 EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Mitsubishi UFJ Kokusai Asset Management Co. Ltd. Sells 1,525 Shares of Henry Schein, Inc. (HSIC)” was published by Community Financial News and is owned by of Community Financial News. If you are viewing this story on another website, it was illegally copied and republished in violation of US & international copyright and trademark laws. The original version of this story can be read at https://www.com-unik.info/2017/08/16/mitsubishi-ufj-kokusai-asset-management-co-ltd-sells-1525-shares-of-henry-schein-inc-hsic.html.

A number of equities research analysts recently issued reports on HSIC shares. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Northcoast Research upgraded Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective on the stock in a research report on Monday, August 7th. BidaskClub downgraded Henry Schein from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Jefferies Group LLC reiterated a “hold” rating and issued a $177.00 price objective on shares of Henry Schein in a research report on Friday, July 21st. Finally, Piper Jaffray Companies started coverage on Henry Schein in a research report on Monday, June 12th. They issued a “neutral” rating and a $200.00 price objective on the stock. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have assigned a buy rating to the company. Henry Schein currently has an average rating of “Hold” and a consensus price target of $185.56.

About Henry Schein

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

What are top analysts saying about Henry Schein Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Henry Schein Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit